维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

12篇 您的检索式：作者名="Lioudaki"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	The estrogenic burden on vascular risk in male-to-female transsexuals显示文摘	Lioudaki E Ganotakis ES Mikhailidis DP	2010	Curr Pharm Des2010，16，34：	1
	2	Microalbuminuria: A Neglected Cardiovascular Risk Factor in Non-diabetic Individuals?显示文摘	Eirini Lioudaki Matilda Florentin Emmanuel S. Ganotakis Dimitri P. Mikhailidis	2013	Current Pharmaceutical Design2013，，27：	1
	3	Prevalence of metabolic syndrome according to different definitions in a hypertensive population显示文摘	Eirini Lioudaki George E Vrentzos Helen Mavrogeni	2012	Angiology2012，63，1：	1
	4	A middleware architecture for privacy protection显示文摘	LIOUDAKIS G	2007	Computer Networks2007，51，16：	1
	5	Increased urinary excretion of podocyte markers in normoalbuminuric patients with diabetes显示文摘	Lioudaki E Stylianou KG Petrakis I	2015	Nephron2015，131，1：	1
	6	Impact of ezetimibe coadministered with statins on cardiovascular events following acute coronary syndrome, a 3 - year population - based retrospective cohort study in Taiwan显示文摘	Katsiki N Lioudaki E Ganotakis ES	2011	Clinical Therapeutics2011，33，12：	1
	7	Liver Enzymes: Potential Cardiovascular Risk Markers?显示文摘	Eirini Lioudaki Emmanuel S. Ganotakis Dimitri P. Mikhailidis	2011	Current Pharmaceutical Design2011，，33：	1
	8	Lipid lowering drugs and gallstones:a therapeutic option显示文摘	Lioudaki E Ganotakis ES Mikhailidis DE	2011	Curr Pharm Des2011，17，：	1
	9	Microalbuminuria: a neglected cardio- vascular risk factor in non -diabetic individuals 显示文摘	Lioudaki E Florentin M	2013	Curt Pharm Des2013，19，27：	1
	10	显示文摘	Lioudakis E Othonos A Hadjisavvas G C	2007	Phys E2007，38，：	1
	11	Liver enzymes: po?tential cardiovascular risk markers? 显示文摘	Mikhailidis DP Lioudaki E Ganotakis ES	2011	CurrPharm Des2011，17，33：	1
	12	Advances in determining abdominal aortic aneurysm size and growth显示文摘Abdominal aortic aneurysm is a common pathology in the aging population of the developed world which carries a significant mortality in excess of 80% in case of rupture. Aneurysmal disease probably represents the only surgical condition in which size is such a critical determinant of the need for intervention and therefore the ability to accurately and reproducibly record aneurysm size and growth over time is of outmost importance. In the same time that imaging techniques may be limited by intra- and inter-observer variability and there may be inconsistencies due to different modalities [ultrasound, computed tomography(CT)], rapid technologic advancement have taken aortic imaging to the next level. Digital imaging, multidetector scanners, thin slice CT and most- importantly the ability to perform 3-dimensional reconstruction and image post-processing have currently become widely available rendering most of the imaging modalities used in the past out of date. The aim of the current article is to report on various imaging methods and current state of the art techniques used to record aneurysm size and growth. Moreover we aim to emphasize on the future research directions and report on techniques which probably will be widely used and incorporated in clinical practice in the near future.	Nikolaos Kontopodis Stella Lioudaki Dimitrios Pantidis George Papadopoulos Efstratios Georgakarakos Christos V Ioannou	2016	World Journal of Radiology2016，8，2：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费